Year: 2025
Type: article
Study design: Observational Study
Abstract: The development of neurotechnologies offers exciting opportunities for novel brain interventions. Public perception plays a crucial role in determining the success and acceptance of these interventions. This study aimed to understand the general non-expert population's representation of neuromodulation and their preferences for common methods such as pharmaceutical drugs, brain implants, ultrasound, magnetic, and electrical stimulations. We conducted a comprehensive online survey with 784 participants to assess their perception of neuromodulation before and after providing information. We also asked the participants to rank their preferences for different neuromodulation techniques after being provided with information. Statistical analyses included inferential non-linear models and free-text data mining. Our findings revealed that overall, neuromodulation was positively perceived by the participants. Furthermore, providing information resulted in a significant improvement in participants' perception of neuromodulation. Ultrasound stimulation emerged as the most preferred treatment choice, while pharmaceutical drugs were considered a middle-choice option and brain implants ranked last due to safety concerns. Healthcare providers could benefit from enhancing patient education and awareness to promote informed decision-making and improve treatment adherence. Additionally, stakeholders have to address the existing distrust surrounding pharmaceutical drugs and prioritize the development and promotion of safe, non-invasive neuromodulation treatments.
Source: Scientific Reports
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G3278182141, DeepBrain: A novel human brain interface that non-invasively writes using focused ultrasound, Beyond drugs: Non-invasive focused ultrasound brain stimulation as a novel intervention for mental health, G6749892856, NeuroMod+: Co-creation for next-generation neuromodulation therapeutics, G76393611
OpenAlex ID: W4407591660